[ad_1] CHICAGO – According to the small EMPA-HEART Cardiolink-6 trial presented here, changes in the structure and function of the left ventricle could help explain how SGLT-2 inhibitors improve cardiovascular health. In …
Read More »[ad_1] CHICAGO – According to the small EMPA-HEART Cardiolink-6 trial presented here, changes in the structure and function of the left ventricle could help explain how SGLT-2 inhibitors improve cardiovascular health. In …
Read More »